Sleep apnea does not affect all people equally. Prevalence, symptom presentation, diagnosis rates, and health outcomes vary meaningfully across demographic groups in ways that have direct implications for who gets identified and who does not. The sleep apnea facts and statistics that describe the average patient obscure significant variation beneath the surface — variation that helps explain why certain groups are consistently underdiagnosed and why treatment outcomes differ across populations.
Age — A Risk Factor That Grows Steadily
Sleep apnea prevalence increases with age across all population groups. This is driven by progressive loss of upper airway muscle tone, changes in sleep architecture that reduce the proportion of restorative deep sleep, weight changes associated with aging, and the accumulation of anatomical changes that narrow the airway over time.
In adults aged 30 to 49, moderate to severe sleep apnea affects an estimated 10% of men and 3% of women. In the 50 to 70 age group, those figures rise to approximately 17% of men and 9% of women. In adults over 70, prevalence continues to increase, with some population studies finding that more than half of older adults have an AHI consistent with at least mild sleep apnea.
Despite higher prevalence in older adults, diagnosis rates in this population are complicated by atypical symptom presentation and the tendency to attribute fatigue, cognitive slowing, and mood changes to normal aging rather than to a treatable sleep disorder. Cardiovascular and cognitive consequences that are often attributed to aging alone may in some cases be substantially driven by undiagnosed sleep apnea.
Biological Sex — Different Presentations, Persistent Diagnostic Gaps
The sex difference in sleep apnea prevalence is well established — men are diagnosed with sleep apnea at approximately two to three times the rate of women. This has historically been attributed to higher true prevalence in men, driven by differences in airway anatomy, fat distribution patterns, and hormonal factors that affect upper airway muscle tone.
However, the diagnostic gap between men and women is also partly a product of different symptom presentation. Women with sleep apnea are less likely to present with the classic triad of loud snoring, witnessed apneas, and excessive daytime sleepiness that most effectively prompts clinical suspicion. Instead, women more commonly report insomnia, fatigue, morning headaches, depression, and anxiety — symptoms that map more readily onto mood disorders than onto sleep apnea.
This presentation difference has real diagnostic consequences. Studies examining symptom profiles of women subsequently diagnosed with sleep apnea have found that a substantial proportion had previously been treated for depression or anxiety, often for years, without sleep apnea being considered. The result is a diagnostic lag that is significantly longer for women than for men with equivalent disease severity.
Hormonal factors further complicate the picture. Premenopausal women appear to have some degree of hormonal protection against sleep apnea, with estrogen and progesterone supporting upper airway muscle tone and ventilatory drive. Post-menopausal women show sharply higher rates of sleep apnea, with some studies finding rates approaching those of age-matched men. Women who present with new or worsening sleep symptoms around menopause should have sleep apnea considered as part of the evaluation.
Race and Ethnicity — Underappreciated Differences in Risk and Diagnosis
Racial and ethnic differences in sleep apnea prevalence, severity, and diagnosis represent one of the less discussed dimensions of the condition’s epidemiology, and the data points to meaningful disparities.
African American adults have higher rates of sleep apnea than non-Hispanic white adults at equivalent BMI levels, and tend to have more severe disease when diagnosed. The reasons are not fully understood but likely involve differences in craniofacial anatomy, body fat distribution patterns, and cardiovascular risk profiles that interact with sleep-disordered breathing in ways that amplify its consequences.
Hispanic adults also show elevated sleep apnea prevalence compared to non-Hispanic white adults in population studies. The Hispanic Community Health Study, one of the largest sleep studies conducted in a Hispanic population, found rates of sleep-disordered breathing substantially higher than general population estimates, with a significant proportion of cases undiagnosed.
Asian adults present a distinct pattern. Despite lower average BMI than Western populations — a demographic characteristic that might suggest lower sleep apnea risk — Asian populations have higher rates of sleep apnea than BMI alone would predict. This is attributed to craniofacial anatomical differences, including relatively smaller upper airway dimensions and different jaw structure, that create airway vulnerability at lower body weights. Standard BMI-based risk thresholds developed in Western populations underestimate sleep apnea risk in Asian patients, and clinical awareness of this discrepancy is important for appropriate screening.
Diagnosis rates lag behind prevalence for most minority populations, driven by a combination of reduced healthcare access, lower rates of sleep study referral, and symptom presentation differences that may not be recognized within clinical frameworks developed predominantly in white male populations.
Body Weight — The Strongest Modifiable Risk Factor
The relationship between body weight and sleep apnea is among the most well-documented associations in sleep medicine. Excess body weight — particularly fat distributed around the neck, upper chest, and abdomen — is the single most significant modifiable risk factor for obstructive sleep apnea.
Neck circumference above 17 inches in men and 16 inches in women is associated with substantially elevated sleep apnea risk, regardless of overall BMI. Fat deposits around the neck externally compress the pharyngeal airway, reducing its caliber and increasing collapsibility during sleep.
The relationship is dose-dependent in both directions. A 10% increase in body weight is associated with approximately a six-fold increase in the risk of developing moderate to severe sleep apnea in some population studies. Conversely, weight loss of 10% to 15% has been associated with meaningful reductions in AHI — in some cases sufficient to move a patient from a moderate or severe classification to a mild one, or from mild to subclinical.
Despite this strong relationship, sleep apnea is not exclusively a condition of overweight or obese individuals. Approximately 30% of sleep apnea patients fall within normal BMI ranges, with their apnea driven primarily by anatomical factors rather than weight. Dismissing sleep apnea as unlikely in a patient of normal weight is one of the diagnostic errors that contributes to the large underdiagnosis gap across all demographic groups.